Clinical Trial Detail

NCT ID NCT02800486
Title Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northwell Health
Indications

glioblastoma multiforme

grade III astrocytoma

mixed glioma

Therapies

Cetuximab

Age Groups: adult

No variant requirements are available.